Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade

Purinergic Signalling

Volumn 1, Issue 2, 2005, Pages 111-134

  Cunha, Rodrigo A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

A1 receptors; A2A receptors; Adenosine; Brain; kinase; Neuroprotection

Indexed keywords

ADENOSINE; DENOSINE KINASE; NEUROPROTECTION; RECEPTORS;

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE KINASE; ADENOSINE KINASE INHIBITOR; ANTIPARKINSON AGENT; GLUTAMIC ACID;

AGING; ALZHEIMER DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; DEGENERATIVE DISEASE; ENZYME INHIBITION; EPILEPSY; HYPERPOLARIZATION; NERVE CELL; NERVE INJURY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; REVIEW;

EID: 16344372309     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-005-0649-1     Document Type: Review

References (397)

1. Cunha RA. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem Int 2001; 38: 107-125.
2. Newby AC. Adenosine and the concept of "retaliatory metabolites." Trends Biochem 1984; 9: 42-44.
3. Lefkowitz RJ. Historical review: A brief history and personal retrospective of seven transmembrane receptors. Trends Pharmacol Sci 2004; 25: 413-422.
4. Fredholm BB, Ijzerman AP, Jacobson KA et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
5. 1 receptors and 50-nucleotidase in the brain of some commonly used xperimental animals. Neuroscience 1987; 22: 813-826.
6. 2A receptors and therapeutic applications. Curr Top Med Chem 2003; 3: 413-426.
7. 2A receptor knockout mice. Br J Pharmacol. 2004; 141: 1006-1014.
8. 1 receptors in hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 2004; 370: 270-278.
9. Lupica CR, Cass WA, Zahniser NR, Dunwiddie TV. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther 1990; 252: 1134-1141.
10. 1 adenosine receptors. Mol Pharmacol 1997; 52: 788-797.
11. 2A receptors: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 2004; 88: 726-734.
12. 1 receptors with P2Y 1 receptors in rat brains. FEBS Lett 2002; 531: 299-303.
13. 1 receptors assemble into functionally interacting complexes. J Biol Chem 2004; 276: 18345-18351.
14. 2 receptor-receptor heteromerization: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 2003; 278: 46741-46749.
15. 2A and glutamate mGlu5 receptors: Implications for striatal neuronal function. Proc Natl Acad Sci USA 2002; 99: 11940-11945.
16. 2A receptor signalling. Proc Natl Acad Sci USA 2003; 100: 1322-1327.
17. 1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 1997; 17: 4956-4964.
18. 2-receptors are required to stimulate microglial proliferation. Neurochem Int 1996; 29: 37-42.
19. 1 adenosine receptors that stimulate cellular migration. Glia 2003; 44: 166-172.
20. 1 receptors are located predominantly on axons in the rat hippocampal formation. J Comp Neurol 1995; 363: 517-531
21. Phillips GR, Huang JK, Wang Y et al. The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution. Neuron 2001; 32: 1-20.
22. Tetzlaff W, Schubert P, Kreutzberg GW. Synaptic and extrasynaptic localization of adenosine binding sites in the rat hippocampus. Neuroscience 1987; 21: 869-875.
23. 1 receptors in nerve terminals and synapses of the rat hippocampus. Brain Res 2003; 987: 49-58.
24. 2A receptors. Prog Neurobiol 1999; 59: 355-396.
25. 2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol 2001; 431: 331-346.
26. 2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 2004; (in press).
27. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 1996; 16: 605-611.
28. 2A receptor interactions in the striatum. Implicationsfor drug therapy in neuro-psychiatric disorders and drug abuse. Curr Med Chem 2003; 3: 1-26.
29. 2A receptors in the rat hippocampus. Brain Res 1994; 649: 208-216
30. 2A receptors to facilitate acetylcholine release in the rat hippocampus. Eur J Pharmacol 2002; 454: 31-38.
31. 2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J Neurophysiol 2003; 90: 1295-303.
32. 1 receptor inhibition. Neuroscience 2002; 112: 319-329.
33. 2A receptors in the hippocampus and striatum of the rat. Neuroscience 2005; in press.
34. 3 H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 1994; 63: 207-214.
35. 2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 355: 48-56.
36. Okada M, Nutt DJ, Murakami T et al. Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci 2001; 21: 628-640.
37. 3H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 2000; 39: 1156-1167.
38. 2A receptors associated with norepinephrine release and their desensitisation in the rat nucleus tractus solitarius. J Neurochem 1995; 65: 1604-1611.
39. 2A adenosine receptors. Life Sci 2001; 68: 1343-1350.
40. 2A adenosine receptors. Glia 2002; 39: 133-147.
41. 2a-receptors in cultured rat microglia. Glia 1999; 25: 120-130.
42. Fiebich BL, Biber K, Lieb K et al. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia 1996; 18: 152-160.
43. Coney AM, Marshall JM. Role of adenosine and its receptors in the vasodilatation induced in the cerebral cortex of the rat by systemic hypoxia. J Physiol 1998; 509: 507-518.
44. Ngai AC, Coyne EF, Meno JR et al. Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol 2001; 280: H2329-H2335.
45. Diáz-Hernández M, Pereira MF, Pintor J et al. Modulation of the rat hippocampal dinucleotide receptor by adenosine receptor activation. J Pharmacol Exp Ther 2002; 301: 441-450.
46. 3 receptors are located in neurons of the rat hippocampus. NeuroReport 2003; 14: 1645-1648.
47. 2A receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 2001; 40: 85-95.
48. 3 receptors: Modulation of synaptic plasticity inthe rat hippocampus. Neurosci Lett 2001; 302: 53-57.
49. 3 receptors and viability in astrocytes. Drug Dev Res 1998; 45: 379-386.
50. 3 receptors in microglia cells. J Neurochem 2003; 86: 1051-1054.
51. 2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression. Am J Physiol 2003; 284: C696-704.
52. 2+ current in hippocampal CA3 neurons. Neuron 1993; 10: 327-334.
53. Phillis JW, Wu PH. The role of adenosine and its nucleotides incentral synaptic transmission. Prog Neurobiol 1981; 16: 187-239.
54. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001; 24: 31-55.
55. Greene RW, Haas HL. The electrophysiology of adenosine in the mammalian central nervous system. Prog Neurobiol 1991; 36: 329-341.
56. 1 receptor. Proc Natl Acad Sci USA 2001; 98: 9407-9412.
57. Proctor WR, Dunwiddie TV. Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus. Brain Res 1987; 426: 187-190.
58. Thompson SM, Haas HL, Gähwiler BH. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol 1992; 451: 347-363.
59. Moore KA, Nicoll RA, Schmitz D. Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 2003; 24: 14397-14402.
60. 6- cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats. Neuropharmacology 2001; 40: 657-667.
61. de Mendonça A, Ribeiro JA. Adenosine and neuronal plasticity. Life Sci 1997; 60: 245-251
62. 1 receptor activation. NeuroReport 1995; 6: 1097-1100.
63. 2+ -dependent manner. Neuroscience 1995; 65: 947-953.
64. 2 receptor mediation of pre- and postsynaptic excitatory effects of adenosine in rat hippocampus in vitro. Eur J Pharmacol 1998; 347: 173-182.
65. 2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. Neuroscience 2005; in press.
66. 2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 1999; 82: 3196-3203.
67. Sebastião AM, Ribeiro JA. Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 2000; 21: 341-346.
68. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol 1994; 271: 349-355.
69. 3H]- acetylcholine release from the rat motor nerve terminals. Eur J Neurosci 2002; 15: 1728-1736.
70. 3H]-ACh release from rat motor nerve endings. Br J Pharmacol 1994; 111: 582-588.
71. 3 H]-acetylcholine release from the rat motor nerve terminals Neurosci. Lett. 2001; 309: 101-104
72. 1 receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br J Pharmacol 2000; 129: 374-380
73. 3 H]-GABA release from hippocampal synaptosomes. Drug Dev Res 2000; 50: 83.
74. 2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 2004; 24: 2905-2913.
75. Lee FS, Chao MV. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci USA 2001; 98: 3555-3560.
76. 2A receptormediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens. J Neurochem 2003; 85: 740-748.
77. Hosli E, Hosli L. Autoradiographic studies on the uptake of adenosine and on binding of adenosine analogues in neurons and astrocytes of cultured rat cerebellum and spinal cord. Neuroscience 1988; 24: 621-628.
78. 2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Br J Pharmacol 1994; 111: 191-198.
79. 2 adenosine receptor cooperation. Eur J Neurosci 1996; 8: 1124-1131.
80. Pilitsis JG, Kimelberg HK. Adenosine receptor mediated stimulation of intracellular calcium in acutely isolated astrocytes. Brain Res 1998; 798: 294-303.
81. 1-receptors in astrocyte cultures affects coupling to the phosphoinositol signaling pathway. Neuropsychopharmacology 1999; 20: 271-278.
82. Ciccarelli R, Ballerini P, Sabatino G et al. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 2001; 19: 395-414.
83. Hindley S, Herman MA, Rathbone MP. Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res 1994; 38: 399-406.
84. 2A adenosine receptors prevents basic fibroblast growth factor-induced reactive strogliosis in rat striatal primary astrocytes. Glia 2003; 43: 190-194.
85. Schwaninger M, Neher M, Viegas E et al. Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine. J Neurochem 1997; 69: 1145-1150.
86. 2A adenosine receptor inhibits nitric oxide production in glial cells. FEBS Lett 1998; 429: 139-142.
87. 1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 1999; 27: 275-281.
88. 3. receptorinduced CCL2 synthesis in cultured mouse astrocytes. Glia 2004; 46: 410-418.
89. 1 receptors. Neuropharmacology 1999; 38: 1511-1517.
90. Cormier RJ, Mennerick S, Melbostad H, Zorumski CF. Basal levels of adenosine modulate mGluR5 on rat hippocampal astrocytes. Glia 2001; 33: 24-35.
91. 1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes. Br J Pharmacol 1995; 115: 801-810.
92. 1 adenosine receptor potentiates the alpha 1-adrenergic activation of phospholipase C in primary cultures of mouse striatal astrocytes. Neurosci Lett 1992; 145: 15-18.
93. 2B receptor stimulation and other signals coupled to Gs proteins in type-1 cerebellar astrocytes. Glia 1999; 26: 119-128.
94. 2 adenosine receptors in cultured cortical astrocytes. Br J Pharmacol 2004; 141: 935-942.
95. Schwaninger M, Petersen N, Prinz S et al. Adenosine-induced expression of interleukin-6 in astrocytes through protein kinase A and NF-IL-6. Glia 2000; 31: 51-58.
96. Fiebich BL, Biber K, Gyufko K et al. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem 1996; 66: 1426-1431.
97. Si QS, Nakamura Y, Schubert P et al. Adenosine and propentofylline inhibit the proliferation of cultured microglial cells. Exp Neurol 1996; 137: 345-349.
98. Flavin MP, Ho LT. Propentofylline protects neurons in culture from death triggered by macrophage or microglial secretory products. J Neurosci Res 1999; 56: 54-59.
99. Wollmer MA, Lucius R, Wilms H et al. ATP and adenosine induce ramification of microglia in vitro. J Neuroimmunol 2001; 115: 19-27.
100. Schubert P, Ogata T, Ferroni S et al. Modulation of glial cell signaling by adenosine and pharmacological reinforcement. A neuroprotective strategy? Mol Chem Neuropathol 1996; 28: 185-190.
101. 13C NMR spectroscopy. J Neurochem 2000; 74: 327-333.
102. 13C MR spectroscopy. J Neurochem 2001; 79: 885-892.
103. Magistretti PJ, Hof PR, Martin JL. Adenosine stimulates glycogenolysis in mouse cerebral cortex: A possible coupling mechanism between neuronal activity and energy metabolism. J Neurosci 1986; 6: 2558-2562.
104. Sorg O, Magistretti PJ. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res 1991; 563: 227-233.
105. Rathbone MP, Middlemiss PJ, Gysbers JW et al. Trophic effects of purines in neurons and glial cells. Prog Neurobiol 1999; 59: 663-690.
106. JD Geiger DM Fyda 1991 Adenosine transport in nervous system tissues TW Stone Adenosine in the Nervous System Academic Press London 1-23
107. MacDonald WF, White TD. Nature of extrasynaptosomal accumulation of endogenous adenosine evoked by K + and veratridine. J Neurochem 1985; 45: 791-797.
108. Cunha RA, Almeida T, Ribeiro JA. Modification by arachidonic acid of extracellular adenosine metabolism and neuromodulatory action in the rat hippocampus. J Biol Chem 2000; 275: 37572-37581.
109. Cunha RA. Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 2001; 26: 979-991.
110. Zimmermann H. Signalling via ATP in the nervous system. Trends Neurosci 1994; 17: 420-426.
111. Wieraszko A, Goldsmith G, Seyfried TN. Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 1989; 485: 244-250.
112. Cunha RA, Vizi ES, Ribeiro JA, Sebastião AM. Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 1996; 67: 2180-2187.
113. 2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol 1996; 76: 3910-3919.
114. 3H]acetylcholine release from the rat motor nerve terminals. Neuroscience 1996; 73: 85-92
115. 2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br J Pharmacol 1997; 122: 1279-1284.
116. 2A receptor activation tonically enhances the magnitude of LTP in the rat hippocampus. 4th Forum of European Neuroscience 2004; A015.14.
117. Cunha RA, Correia-de-Sá P, Sebastião AM, Ribeiro JA. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br J Pharmacol 1996; 119: 253-260.
118. Cunha RA, Almeida T, Ribeiro JA. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats. J Neurochem 2001; 76: 372-382.
119. 3 H]aspartate release in cultured retina cells exposed to oxidative stress. Neurochem Int 2000; 36: 255-265.
120. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur J Neurosci 2003; 18: 820-828.
121. 2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J Biol Chem 1999; 274: 20358-20365.
122. Kobayashi S, Zimmermann H, Millhorn DE. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J Neurochem 2000; 74: 621-632.
123. 2a denosine receptor in a human B cell line. Biol Chem 2003; 384: 483-487
124. Latini S, Pedata F. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J Neurochem 2001; 79: 463-484.
125. Bodin P, Burnstock G. Purinergic signalling: ATP release. Neurochem Res 2001; 268: 959-969.
126. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Arch Pharmacol 2000; 362: 299-309.
127. 1 receptors. J Neurosci 1998; 18: 1987-1995.
128. Dunwiddie TV, Diao L, Proctor WR. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 1997; 17: 7673-7682.
129. Rusakov DA, Harrison E, Stewart MG. Synapses in the hippocampus occupy only 1-2% of cell membranes and are spaced less than half-micron apart: A quantitative ultrastructural analysis with discussion of physiological implications. Neuropharmacology 1998; 37: 513-521.
130. Cunha RA, Brendel P, Zimmermann H, Ribeiro JA. Immunologically distinct isoforms of ecto-5′-nucleotidase in nerve terminals of different areas of the rat hippocampus. J Neurochem 2000; 74: 334-338.
131. Wang Z, Haydon PG, Yeung ES. Direct observation of calcium-independent intercellular ATP signaling in astrocytes. Anal Chem 2000; 72: 2001-2007.
132. Arcuino G, Lin JH, Takano T et al. Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci USA 2002; 99: 9840-9845.
133. Coco S, Calegari F, Pravettoni E et al. Storage and release of ATP from astrocytes in culture. J Biol Chem 2003; 278: 1354-1362.
134. Stout CE, Costantin JL, Naus CC, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002; 277: 10482-10488.
135. Ballerini P, Di Iorio P, Ciccarelli R et al. Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. NeuroReport 2002; 13: 1789-1792.
136. Bal-Price A, Moneer Z, Brown GC. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 2002; 40: 312-323.
137. Anderson CM, Bergher JP, Swanson RA. ATP-induced ATP release from astrocytes. J Neurochem 2004; 88: 246-256.
138. Parkinson FE, Xiong W. Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J Neurochem 2004; 88: 1305-1312.
139. Koizumi S, Fujishita K, Tsuda M et al. Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci USA 2003; 100: 11023-11028.
140. Newman EA. Glial cell inhibition of neurons by release of ATP. J Neurosci 2003; 23: 1659-1666.
141. Zhang JM, Wang HK, Ye CQ et al. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 2003; 40: 971-982.
142. Seo DR, Kim KY, Lee YB. Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion. NeuroReport 2004; 15: 1157-1161.
143. Rosenberg PA, Li Y. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res 1995; 692: 227-232.
144. Brundege JM, Diao L, Proctor WR, Dunwiddie TV. The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology 1997; 36: 1201-1210.
145. Fowler JC. Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice. Naunyn-Schmiedeberg's Arch Pharmacol 1993; 347: 73-78.
146. Doolette DJ. Mechanism of adenosine accumulation in the hippocampal slice during energy deprivation. Neurochem Int 1997; 30: 211-223.
147. Phillis JW, O'Regan MH, Walter GA. Effects of deoxycoformycin on adenosine, inosine, hypoxanthine, xanthine, and uric acid release from the hypoxemic rat cerebral cortex. J Cereb Blood Flow Metab 1988; 8: 733-741.
148. Kobayashi T, Yamada T, Okada Y. The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia -in vivo study. Brain Res 1998; 787: 211-219.
149. Wieraszko A, Seyfried TN. Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci Lett 1989; 106: 287-293.
150. Lutz PL, Kabler S. Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia. Brain Res 1997; 769: 281-286.
151. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 1999; 823: 183-190.
152. Parkinson FE, Sinclair CJ, Othman T et al. Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions. Neuropharmacology 2002; 43: 836-846.
153. VolontéC, Amadio S, Cavaliere F et al. Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2003; 2: 403-412.
154. Liu GJ, Bennett MR. ATP secretion from nerve trunks and Schwann cells mediated by glutamate. NeuroReport 2003; 14: 2079-2783.
155. Brown P, Dale N. Spike-independent release of ATP from Xenopus spinal neurons evoked by activation of glutamate receptors. J Physiol 2002; 540: 851-860.
156. Vizi ES, Sperlagh B. Receptor- and carrier-mediated release of ATP of postsynaptic origin: Cascade transmission. Prog Brain Res 1999; 120: 159-169.
157. Braun N, Zhu Y, Krieglstein J et al. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 1998; 18: 4891-4900.
158. Bonan CD, Walz R, Pereira GS et al. Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy. Epilepsy Res 2000; 39: 229-238.
159. Fontella FU, Bruno AN, Crema LM et al. Acute and chronic stress alter ecto-nucleotidase activities in synaptosomes from the rat hippocampus. Pharmacol Biochem Behav 2004; 78: 341-347.
160. Zhang G, Franklin PH, Murray TF. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J Pharmacol Exp Ther 1993; 264: 1415-1424.
161. Miller LP, Jelovich LA, Yao L et al. Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats. Neurosci Lett 1996; 220: 73-76.
162. Jiang N, Kowaluk EA, Lee CH et al. Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur J Pharmacol 1997; 320: 131-137.
163. Tatlisumak T, Takano K, Carano RA et al. Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion. Stroke 1998; 29: 1952-1958.
164. Wiesner JB, Ugarkar BG, Castellino AJ et al. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J Pharmacol Exp Ther 1999; 289: 1669-1677.
165. Gouder N, Scheurer L, Fritschy JM, Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 2004; 24: 692-701.
166. McGaraughty S, Cowart M, Jarvis MF. Recent developments in the discovery
167. Delaney SM, Sutherland GR, Peeling J, Geiger JD. Failure of 2′-deoxycoformycin to protect against transient forebrain ischemia in rat. Neurosci Lett 1993; 149: 31-4.
168. Zhu PJ, Krnjevic K. Endogenous adenosine deaminase does not modulate synaptic transmission in rat hippocampal slices under normoxic or hypoxic conditions. Neuroscience 1994; 63: 489-497.
169. Phillis JW, O'Regan MH. Deoxycoformycin antagonizes ischemia-induced neuronal degeneration. Brain Res Bull 1989; 22: 537-540.
170. Barankiewicz J, Danks AM, Abushanab E et al. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. J Pharmacol Exp Ther 1997; 283: 1230-1238.
171. de Mendonça A, Sebastião AM, Ribeiro JA. Adenosine: Does it have a neuroprotective role after all? Brain Res Brain Res Rev 2000; 33: 258-274.
172. Fredholm BB. Adenosine and neuroprotection. Int Rev Neurobiol 1997; 40: 259-280.
173. Sweeney MI. Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity. Neurosci Biobehav Rev 1997; 21: 207-217.
174. von Lubitz DK. Adenosine and cerebral ischemia: Therapeutic future or death of a brave concept? Eur J Pharmacol 1999; 371: 85-102.
175. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev 1992; 4: 346-369.
176. Phillis JW, Goshgarian HG. Adenosine and neurotrauma: Therapeutic perspectives. Neurol Res 2001; 23: 183-189.
177. 1 receptor binding reduces hypoxic-ischemic brain injury in newborn rats. Brain Res 1997; 759: 309-312.
178. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 1997; 79: 2-10.
179. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990; 70: 761-989.
180. Brodie MS, Lee KS, Fredholm BB et al. Central versus peripheral mediation of responses to adenosine receptor agonists: Evidence against a central mode of action. Brain Res 1987; 415: 323-333.
181. 1 receptor agonists. J Pharmacol Exp Ther 2004; in press.
182. 1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders. Ann NY Acad Sci 1997; 825: 23-29.
183. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB. Adenosine receptor ligands: Differences with acute versus chronic treatment. Trends Pharmacol Sci 1996; 17: 108-113.
184. 1 AR mRNA or G-protein alpha-subunit content. J Neurochem 1998; 71: 221-230.
185. 1 adenosine receptors. J Neurosci 2002; 22: 1248-1255.
186. 2 receptors. Eur J Pharmacol 1992; 227: 317-324.
187. 1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells. Neurochem Res 1998; 23: 211-218.
188. Fernandez M, Svenningsson P, Fredholm BB. Adaptative changes in adenosine receptors following long-term treatment with the adenosine receptor agonist R-phenylisopropyl adenosine. Life Sci 1996; 58: 769-776.
189. 1 receptors in rat brain by in vivo treatment with R-PIA: Involvement of coated vesicles. Biochem Biophys Acta 1996; 1310: 168-174.
190. Lewin E, Bleck V. Electroshock seizures in mice: Effect on brain adenosine and its metabolites. Epilepsia 1981; 22: 577-581.
191. During MJ, Spencer DD. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 1992; 32: 618-624.
192. Berman RF, Fredholm BB, Aden U, O'Connor WT. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res 2000; 872: 44-53.
193. 1 receptors in epilepsy. NeuroReport 1999; 10: 3535-3541.
194. 1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci Lett 2000; 284: 49-52.
195. 2A receptors in the rat cerebral cortex. Epilepsia 2004; in press.
196. 1 receptors in dementia: Evidence for lack of specificity. Neurosci Lett 1998; 244: 1-4.
197. 1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study. Neurosci Lett 1993; 163: 11-14.
198. Young D, Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 1994; 58: 245-261.
199. 2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur J Pharmacol 1995; 294: 383-389.
200. 1 binding sites after transient forebrain ischemia in the gerbil. Brain Res 1987; 415: 309-322.
201. Lee KS, Tetzlaff W, Kreutzberg GW. Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Res 1986; 380: 155-158.
202. 1 receptor inding in the post-ischaemic rat brain. NeuroReport 1994; 5: 1453-1456.
203. Coelho JE, deMendonça A, Cunha RA, Ribeiro JA. Hypoxia induces a functional desensitisation of adenosine receptors. 4th Forum of European Neurosciences 2004; A048.6.
204. de Mendonça A, Costenla AR, Ribeiro JA. Persistence of the neuromodulatory effects of adenosine on synaptic transmission after long-term potentiation and long-term depression. Brain Res 2002; 932: 56-60.
205. Youssef FF, Addae JI, Stone TW. LTP-induced depression of response to hypoxia in hippocampus: Effects of adenosine receptor activation. NeuroReport 2003; 14: 1809-1814.
206. 1 receptors in dementia: Evidence for lack of specificity. Neurosci Lett 1998; 244: 1-4.
207. 1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol 2003; 13: 440-451.
208. 2A receptor mRNA by dopamine denervation. Eur J Pharmacol 2002; 446: 75-82.
209. 2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA. Synapse 2004; 52: 218-222.
210. 2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 2004; 127: 1075-1084.
211. 2 receptors: Selective localization in the human basal ganglia and alterations with disease. Neuroscience 1991; 42: 697-706.
212. 2A receptor mRNA expression in Parkinson's disease. Neurosci Lett 2000; 291: 54-58.
213. 2A receptor signaling in striatal cells expressing mutant huntingtin. FASEB J 2001; 15: 1245-1247.
214. Glass M, Dragunow M, Faull RL. The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA A receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 2000; 97: 505-519.
215. 11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging Ann. Nucl. Med. 2002; 16: 467-475
216. 2A immunoreactivity in activated rat microglia in culture. 4th Forum of European Neuroscience 2004; A223.9.
217. 2A adenosine receptors by proinflammatory cytokines in rat PC12 cells. Biochem Pharmacol 2002; 64: 625-631.
218. 2A receptors in PC12 cells and increases receptor-mediated formation of AMP. Naunyn-Schmiedeberg's Arch Pharmacol 2002; 365: 150-157.
219. Suzuki T, Hashimoto S, Toyoda N et al. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000; 96: 2584-2591.
220. Schnurr M, Toy T, Shin A et al. Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 2004; 103: 1391-1397.
221. Panther E, Idzko M, Herouy Y et al. Expression and function of adenosine receptors in human dendritic cells. FASEB J 2001; 15: 1963-1970.
222. Nguyen DK, Montesinos MC, Williams AJ et al. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 2003; 171: 3991-3998.
223. 2A receptor agonists and endotoxin. Am J Pathol 2002; 160: 2231-2244.
224. 2A receptors in schizophrenia. NeuroReport 2003; 14: 313-316.
225. Gao Y, Phillis JW. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 1994; 55: 61-65.
226. 2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 1995; 705: 79-84.
227. 2A receptor agonist and antagonist. Eur J Pharmacol 1995; 287: 295-302.
228. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport 1998; 9: 3955-3959.
229. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 1999; 19: 9192-9200.
230. Tebano MT, Domenici MR, Popoli P. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices. Eur J Pharmacol 2002; 450:253-257.
231. 2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 2003; 959: 243-250.
232. 2A receptor antagonists. Br J Pharmacol 2002; 135: 1435-1442.
233. 2A adenosine receptors leads to c- fos inhibition in a rat model of brain ischemia. Pharmacol Res 2002; 45: 125-128.
234. Higashi H, Meno JR, Marwaha AS, Winn HR. Hippocampal injury and neurobehavioral deficits following hyperglycemic cerebral ischemia: Effect of theophylline and ZM 241385. J Neurosurg 2002; 96: 117-126.
235. 2A receptor antagonist. Brain Res 1998; 800: 328-335.
236. Lee HK, Choi SS, Han KJ et al. Roles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice. Mol Brain Res 2004; 125: 76-85
237. 2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease. Brain Res 1999; 831: 315-318.
238. 2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: Possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J Neurosci 2002; 22: 1967-1975.
239. 2A antagonists. J Neurosci 2003; 23: 5361-5369.
240. 2A receptor attenuates 3-nitropropionic acid-induced striatal damage. J Neurochem 2004; 88: 538-544.
241. Alfinito PD, Wang SP, Manzino L et al. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. J Neurosci 2003; 23: 10982-10987.
242. 2A adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 2001; 21: RC143.
243. 2A receptor blockade in experimental models of Parkinson's disease. J Neurochem 2002; 80: 262-270.
244. Xu K, Xu YH, Chen JF, Schwarzschild MA. Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett 2002; 322: 13-16.
245. 2A receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake. Neuropsychopharmacology 2000; 22: 522-529.
246. 2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 2004; 88: 1151-1158.
247. 2A adenosine receptor antagonist, SCH 58261, in the rat. J Pharmacol Exp Ther 1998; 285: 9-15.
248. 2A receptor modulation. Neurology 2003; 61(Suppl 6): S88-S93.
249. 2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 1992; 138: 169-172.
250. 2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol 2002; 136: 434-440.
251. 2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices. Neuropharmacology 2003; 45: 201-210.
252. Nikbakht MR, Stone TW. Suppression of presynaptic responses to adenosine by activation of NMDA receptors. Eur J Pharmacol 2001; 427: 13-25.
253. 2A adenosine receptors differentially regulate spontaneous and K + -evoked glutamate release in vivo in young and aged rats. NeuroReport 1999; 10: 687-591.
254. 2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. NeuroReport. 2000; 11: 2591-2595.
255. + -evoked glutamate release in the striatum. Eur J Pharmacol 2001; 421: 177-180.
256. 2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease. Brain Res 2003; 979: 225-229.
257. 2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum. J Neurosci Res 2004; 77: 100-107.
258. 2Areceptors. Neurology 2003; 61(Suppl 6): S69-S71.
259. Sebastião AM, de Mendonça A, Moreira T, Ribeiro JA. Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J Neurosci 2001; 21: 8564-8571.
260. 2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 1999; 128: 1035-1044.
261. 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J Neurochem 2004; 89: 152-156.
262. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000; 403: 316-31.
263. 2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol 2003; 138: 1207-1209.
264. 195.4
265. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
266. Turner PR, O'Connor K, Tate WP, Abraham WC. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 2003; 70: 1-32.
267. 2a receptors: Implications for the treatment of Parkinson's disease. J Neurosci 2000; 20: 7782-7789.
268. 2A receptor-induced inhibition of NMDA and GABA A receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology 2004; 46: 994-1007.
269. 2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons. Eur J Pharmacol 2002; 451: 161-164.
270. Robledo P, Ursu G, Mahy N. Effects of adenosine and gamma-aminobutyric acid A receptor antagonists on N -methyl- d -aspartate induced neurotoxicity in the rat hippocampus. Hippocampus 1999; 9: 527-533.
271. 2A adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J Biol Chem 2001; 276: 13838-13846.
272. 2A receptors regulate oxidative stress formation in rat pheochromocytoma PC12 cells during serum deprivation. Neurosci Lett 2003; 350: 127-131.
273. 2A receptor protects sympathetic neurons against nerve growth factor withdrawal. J Neurosci Res 2004; 77: 258-269.
274. 2a receptor activation delays apoptosis in human neutrophils. J Immunol 1997; 158: 2926-2931.
275. 2A receptor antagonism. J Leukoc Biol 2000; 67: 529-535.
276. Zhao ZQ, Budde JM, Morris C et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol 2001; 33: 57-68.
277. Schubert P, Rudolphi K. Interfering with the pathologic activation of microglial cells and astrocytes in dementia. Alzheimer Dis Assoc Disord 1998; 12(Suppl 2): S21-S28.
278. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond, B 2003; 358: 1669-1677.
279. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003; 304: 1-7.
280. Neuman H. The immunological microenvironment in the CNS: Implications on neuronal cell death and survival. J Neural Transm 2000; 59: 59-68.
281. Kato H, Walz W. The initiation of the microglia response. Brain Pathol 2000; 10: 137-143.
282. Neuroinflammation Working Group. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421.
283. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-318.
284. 2A receptors prevents kainate-induced convulsions and neuronal cell death. 4th International Symposium of Nucleosides and Nucleotides 2004; 69T.
285. 2A receptors attenuates inflammatory responses in the central nervous systems. 4th Forum of European Neuroscience 2004; A023.11.
286. Kim WG, Mohney RP, Wilson B et al. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity: Role of microglia. J Neurosci 2000; 20: 6309-6316.
287. Kloss CU, Bohatscheck M, Kreutzberg GW, Raivich G. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in mouse brain and in cell culture. Exp Neurol 2001; 168: 32-46.
288. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002; 40: 140-155.
289. de Simone R, Ajmone-Cat MA, Minghetti L. Atypical anti-inflammatory activation of microglia induced by apoptotic neurons: Possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol Neurobiol 2004; 29: 197-212
290. Jensen MB, Finsen B, Zimmer J. Morphological and immunophenotypic microglial changes in denervated fascia dentate of adult rats: Correlation with blood brain barrier damage and astroglial reactions. Exp Neurol 1997; 143: 103-106.
291. Lyons SA, Pastor A, Ohlemeyer C et al. Distinct physiologic properties of microglia and blood-borne cells in rat brain slices after permanent middle cerebral artery occlusion. J Cereb Blood Flow Met 2000; 20: 1537-1549.
292. 2A receptors in bone marrow cells reveals their critical role in the development of ischemic brain injury. 4th International Symposium of Nucleosides and Nucleotides 2004; 67T.
293. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13.
294. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414: 916-920.
295. 2A receptors. Annu Rev Immunol 2004; 22: 657-682.
296. Hasko G, Cronstein BN. Adenosine: An endogenous regulator of innate immunity. Trends Immunol 2004; 25: 33-39.
297. 2A receptor in the modulation of myocardial reperfusion damage. J Cardiovasc Pharmacol 1999; 33: 883-893.
298. 2A receptors. J Auton Pharmacol 2001; 21: 263-271.
299. 2A receptor activation. Am J Physiol 2003; 284: H2360-H2367.
300. 2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 2001; 21: 791-796.
301. 2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol 2000; 279: F809-F818.
302. 2A adenosine receptors on bone marrow-derived cells. J Clin Invest 2003; 112: 883-891.
303. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther 2000; 294: 1034-1042.
304. 2A adenosine receptors during reperfusion: Inhibition of chemokine induction. Am J Physiol 2004; 286: G285-G293.
305. Khimenko PL, Moore TM, Hill LW et al. Adenosine A2 receptors reverse ischemia-reperfusion lung injury independent of beta-receptors. J Appl Physiol 1995; 78: 990-996.
306. 2A activation reduces lung reperfusion injury following transplantation. J Heart Lung Transplant 1999; 18: 994-1002.
307. Cohen SB, Gill SS, Baer GS et al. Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist. J Orthop Res 2004; 22: 427-435.
308. 2A adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol 2001; 281: H67-H74.
309. 2A receptors. Am J Pathol 2002; 160: 2009-2018.
310. 2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg 2001; 34: 482-488.
311. 2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J Vasc Surg 2002; 35: 994-998.
312. 2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol 2001; 49: 727-735.
313. 2A adenosine receptor inhibits inflammation in a rat model of meningitis: Synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis 1999; 180: 1550-1560.
314. Ritchie PK, Spangelo BL, Krzymowski DK et al. Adenosine increases interleukin 6 release and decreases tumour necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages. Cytokine 1997; 9: 187-198.
315. 2a receptor-dependent and independent mechanisms. FASEB J 2000; 14: 2065-2074.
316. 2A receptors. Am J Pathol 2003; 163: 711-721.
317. 3 receptors. J Immunol 1997; 158: 5400-5408.
318. 2a receptors inhibits IL-12 production by human monocytes. J Immunol 2000; 164: 436-442.
319. 2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol 2002; 72: 1027-1036.
320. 2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997; 90: 1600-1610.
321. 2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency Blood 2000; 95: 3859-3867
322. Linden J. CD4+ T cells are targets of adenosine-mediated tissue protection from ischemia-reperfusion in jury. 4th International Symposium of Nucleosides and Nucleotides 2004.
323. + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA 2002; 99: 15620-15625.
324. + regulatory T-cell activity: Implications for neurodegeneration. J Neurosci 2004; 24: 6133-6143.
325. Stone TW. Purines and neuroprotection. Adv Exp Med Biol 2002; 513: 249-280.
326. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 1997; 18: 338-344.
327. 2A receptor antagonists in animal models of Parkinson's disease. Neurology 2003; 61(Suppl 6): S55-S61
328. 2A receptors in neuroadaptation to repeated dopaminergic stimulation: Implications for the treatment of dyskinesias in Parkinson's disease. Neurology 2003; 61(Suppl 6): S74-S81.
329. 2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease. Neurology 2003; 61(Suppl 6): S97-S100.
330. Huber A, Padrun V, Deglon N et al. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci USA 2001; 98: 7611-7616.
331. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 2003; 44: 877-885.
332. 1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 2004; 24: 1521-159.
333. Richter A, Hamann M. Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia. Br J Pharmacol 2001; 134: 343-352.
334. 1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. J Neurosci 2002; 22: 9122-9133.
335. Lu Y, Chung HJ, Li Y, Rosenberg PA. NMDA receptor-mediated extracellular adenosine accumulation in rat forebrain neurons in culture is associated
336. 1 adenosine receptor expression in rats. Dev Brain Res 1995; 89: 202-213.
337. Doriat JF, Humbert AC, Daval JL. Brain maturation of high-affinity adenosine A2 receptors and their coupling to G-proteins. Dev Brain Res 1996; 93: 1-9.
338. 2A adenosine receptor characteristics following repeated seizures in developing rats. Epilepsy Res 1999; 35: 219-228.
339. 2A receptors in rat brain: Comparison with dopamine receptors. Neuroscience 1997; 80: 1187-1207.
340. Aden U, Lindstrom K, Bona E et al. Changes in adenosine receptors in the neonatal rat brain following hypoxic ischemia. Pediatr Res 2000; 48: 177-183.
341. 1 receptor agonism in the immature rat brain and heart. Eur J Pharmacol 2001; 426: 185-192.
342. Guillet R, Dunham L. Neonatal caffeine exposure and seizure susceptibility in adult rats. Epilepsia 1995; 36: 743-749.
343. Dzhala V, Desfreres L, Melyan Z et al. Epileptogenic action of caffeine during anoxia in the neonatal rat hippocampus. Ann Neurol 1999; 46: 95-102.
344. 1 receptor activation during asphyxia in the fetal sheep. Stroke 2003; 34: 2240-2245.
345. 1 adenosine receptors mediate hypoxia-induced ventriculomegaly. Proc Natl Acad Sci USA 2003; 100: 11718-11722.
346. 1 adenosine receptor activation induces ventriculomegaly and white matter loss. NeuroReport 2002; 13: 1199-1204.
347. Blood AB, Hunter CJ, Power GG. Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep. J Physiol 2003; 553: 935-945.
348. 1 area of rat hippocampus. Dev Brain Res 1990; 55: 147-150.
349. Rivkees SA, Zhao Z, Porter G, Turner C. Influences of adenosine on the fetus and newborn. Mol Genet Metab 2001; 74: 160-171.
350. Bona E, Aden U, Gilland E et al. Neonatal cerebral hypoxia-ischemia: The effect of adenosine receptor antagonists. Neuropharmacology 1997; 36: 1327-1338.
351. 1 receptor and is reduced by nerve growth factor. Dev Brain Res 1998; 105: 167-173.
352. 1 adenosine receptor activation inhibits neurite process formation by Rho kinase-mediated pathways. NeuroReport 2001; 12: 3057-3063.
353. Gidday JM, Fitzgibbons JC, Shah AR et al. Reduction in cerebral ischemic injury in the newborn rat by potentiation of endogenous adenosine. Pediatr Res 1995; 38: 306-311.
354. 2A knockout mice. Stroke 2003; 34: 739-744.
355. 2+ release. Trends Pharmacol Sci 1995; 16: 356-359.
356. Turner CP, Pulciani D, Rivkees SA. Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 2002; 178: 21-32.
357. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurones. J Physiol 1991; 435: 373-393.
358. Obrietan K, Belousov AB, Heller HC, van den Pol AN. Adenosine pre- and postsynaptic modulation of glutamate-dependent calcium activity in hypothalamic neurons. J Neurophysiol 1995; 74: 2150-2162.
359. Sturm CD, Frisella WA, Yoon KW. Attenuation of potassium cyanide-mediated neuronal cell death by adenosine. J Neurosurg 1993; 79: 111-115.
360. Daval JL, Nicolas F. Opposite effects of cyclohexyladenosine and theophylline on hypoxic damage in cultured neurons. Neurosci Lett 1994; 175: 114-116.
361. 1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death. Mol Chem Neuropathol 1997; 31: 119-133.
362. Lobner D, Choi DW. Dipyridamole increases oxygen-glucose deprivation-induced injury in cortical cell culture. Stroke 1994; 25: 2085-2089.
363. Barth A, Newell DW, Nguyen LB et al. Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide. Brain Res 1997; 762: 79-88.
364. Brooke SM, Sapolsky RM. A cautionary note: The actions of adenosine agonists and antagonists may be reversed under certain conditions in primary cultures. Brain Res Bull 2000; 51: 307-312.
365. 2a receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons. Brain Res 2001; 900: 169-176.
366. Paes-de-Carvalho R, Maia GA, Ferreira JM. Adenosine regulates the survival of avian retinal neurons and photoreceptors in culture. Neurochem Res 2003; 28: 1583-1590.
367. Lynch JJ, Alexander KM, Jarvis MF, Kowaluk EA. Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci Lett 1998; 252: 207-210.
368. Lobner D. Saturation of neuroprotective effects of adenosine in cortical culture. NeuroReport 2002; 13: 2075-2078.
369. 1 receptor gene expression in cerebral cortex of aged rats. Neurosci Lett 2000; 283: 227-229.
370. 1 adenosine receptors in cortex, hippocampus and cerebellum in ageing mouse brain. NeuroReport 1992; 3: 735-737.
371. Araki T, Kato H, Kanai Y, Kogure K. Selective changes of neurotransmitter receptors in middle-aged gerbil brain. Neurochem Int 1993; 23: 541-548.
372. 2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. NeuroReport 1995; 6: 1583-1588.
373. 1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur J Biochem 2001; 268: 2939-2947.
374. 1 receptor and uptake site binding in the mouse brain: An autoradiographic study. J Neurosci Res 2000; 60: 257-265.
375. 1 -adenosine receptors in rat hippocampal slices. Int J Dev Neurosci 1997; 15: 739-747.
376. Fredholm BB, Johansson B, Lindstrom K, Wahlstrom G. Age-dependent changes in adenosine receptors are not modified by life-long intermittent alcohol administration. Brain Res 1998; 791: 177-185.
377. 2A receptors in the limbic cortex, but not striatum, of aged rats. J Neurochem 1999; 73: 1733-1738.
378. Giovannelli L, Giovannini MG, Pedata F, Pepeu G. Purinergic modulation of cortical acetylcholine release is decreased in aging rats. Exp Gerontol 1988; 23: 175-181.
379. Pedata F, Slavikova J, Kotas A, Pepeu G. Acetylcholine release from rat cortical slices during postnatal development and aging. Neurobiol Aging 1983; 4: 31-35.
380. Sebastião AM, Cunha RA, de Mendonca A, Ribeiro JA. Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Br J Pharmacol 2000; 131: 1629-1634.
381. 2 receptor in the rat striatum. Neurosci Lett 1993; 158: 121-124.
382. Popoli P, Betto P, Rimondini R et al. Age-related alteration of the adenosine/dopamine balance in the rat striatum. Brain Res 1998; 795: 297-300.
383. 2 receptors in the striatum of young adult and aged rats. Neurochem Int 2004; 45: 733-738.
384. 2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. NeuroReport 2000; 11: 2591-2595.
385. 2A receptor antagonists stimulate motor activity: Evidence for an increased effectiveness in aged rats. Neurosci Lett 1998; 251: 201-204.
386. Barnes CA. Normal aging: Regionally specific changes in hippocampal synaptic transmission. Trends Neurosci 1994; 17: 13-18.
387. Rosenzweig ES, Barnes CA. Impact of aging on hippocampal function: Plasticity, network dynamics, and cognition. Prog Neurobiol 2003; 69: 143-179.
388. 1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur J Neurosci 2002; 16: 547-550.
389. Corsi C, Pazzagli M, Bianchi L et al. In vivo amino acid release from the striatum of aging rats: Adenosine modulation. Neurobiol Aging 1997; 18: 243-250.
390. 1 adenosine receptor antagonism in rat hippocampal slices. J Neurophysiol 1992; 68: 629-638.
391. Gribkoff VK, Bauman LA. Endogenous adenosine contributes to hypoxic synaptic depression in hippocampus from young and aged rats. J Neurophysiol 1992; 68: 620-628.
392. Costenla AR, de Mendonca A, Ribeiro JA. Adenosine modulates synaptic plasticity in hippocampal slices from aged rats. Brain Res 1999; 851: 228-234.
393. 1 receptor and Gα protein coupling in rat ventricular myocardium during aging. Circ Res 1997; 81: 1065-1071.
394. 1 adenosine receptor overexpression. J Physiol 2003; 549: 823-833.
395. Pereira MF, Cunha RA, Ribeiro JA. Tonic adenosine neuromodulation is preserved in motor nerve endings of aged rats. Neurochem Int 2000; 36: 563-566.
396. 1 receptors are decreased in Alzheimer's disease. Neurosci Lett 1990; 118: 257-260.
397. 2A receptor activation tonically enhances the magnitude of LTP in the rat hippocampus. 4th Forum of European Neuroscience 2004; A015.14.